Mr Wong Kum Cheun (KC) is Head of Asia Pacific Policy & Liaison for Novartis Asia Pacific Pharmaceuticals based in the Singapore regional office and leads in the development of regulatory policy guidance and intelligence for Asia Pacific region. KC was also ad-interim Sub-Region Head for Novartis Drug Regulatory Affairs for Asian countries responsible for product regulatory strategy and registration. He is active in regional pharmaceutical harmonization activities in Asia Pacific including the ASEAN pharmaceutical harmonization and APEC LSIF. He is currently the Co-Chair of the ASEAN Pharmaceutical Research Industry Association (APRIA), Co-Chair of Singapore Association of Pharmaceutical Industries (SAPI) Regulatory Affairs Committee, Chair of EFPIA ASEAN Network, member of IFPMA Biotherapeutic Group, EFPIA regional networks, ISPE Asia Pacific Focus Group and Asia Partnership Conference of Pharmaceutical Associations (APAC).
Prior joining Novartis, KC was the Director Global Regulatory Policy & Intelligence Asia Pacific with Janssen of Johnson &Johnson, and formerly Singapore Health Sciences Authority’s Drug Registration Branch’s Deputy Head responsible for leading a team of regulators in the ‘Quality Evaluation and Submissions Section’.